Global Paclitaxel for Injection Market Growth 2022-2028
The global market for Paclitaxel for Injection is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Paclitaxel for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Paclitaxel for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Paclitaxel for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Paclitaxel for Injection market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Paclitaxel for Injection players cover Getwell Pharmaceuticals, CSPC Pharmaceutical Group Limited, AdvaCare Pharma, Pfizer and Bristol-Myers Squibb, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Paclitaxel for Injection market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Paclitaxel for Injection market, with both quantitative and qualitative data, to help readers understand how the Paclitaxel for Injection market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Paclitaxel for Injection market and forecasts the market size by Type (5ml,30mg, 10ml,60mg and Others), by Application (Ovarian Cancer, Breast Cancer, Cervical Cancer and Pancreatic Cancer), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
5ml,30mg
10ml,60mg
Others
Segmentation by application
Ovarian Cancer
Breast Cancer
Cervical Cancer
Pancreatic Cancer
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Getwell Pharmaceuticals
CSPC Pharmaceutical Group Limited
AdvaCare Pharma
Pfizer
Bristol-Myers Squibb
Celgene Corporation
Hospira
Biological E.
Taj Accura
Luye Pharma
Beijing Youcare
Hainan Chuntch Pharmaceutical Co Ltd
Healthiza Lifescience Private Limited
Chapter Introduction
Chapter 1: Scope of Paclitaxel for Injection, Research Methodology, etc.
Chapter 2: Executive Summary, global Paclitaxel for Injection market size (sales and revenue) and CAGR, Paclitaxel for Injection market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Paclitaxel for Injection sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Paclitaxel for Injection sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Paclitaxel for Injection market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Getwell Pharmaceuticals, CSPC Pharmaceutical Group Limited, AdvaCare Pharma, Pfizer, Bristol-Myers Squibb, Celgene Corporation, Hospira, Biological E. and Taj Accura, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paclitaxel for Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Paclitaxel for Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Paclitaxel for Injection by Country/Region, 2017, 2022 & 2028
2.2 Paclitaxel for Injection Segment by Type
2.2.1 5ml,30mg
2.2.2 10ml,60mg
2.2.3 Others
2.3 Paclitaxel for Injection Sales by Type
2.3.1 Global Paclitaxel for Injection Sales Market Share by Type (2017-2022)
2.3.2 Global Paclitaxel for Injection Revenue and Market Share by Type (2017-2022)
2.3.3 Global Paclitaxel for Injection Sale Price by Type (2017-2022)
2.4 Paclitaxel for Injection Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Breast Cancer
2.4.3 Cervical Cancer
2.4.4 Pancreatic Cancer
2.4.5 Others
2.5 Paclitaxel for Injection Sales by Application
2.5.1 Global Paclitaxel for Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Paclitaxel for Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Paclitaxel for Injection Sale Price by Application (2017-2022)
3 Global Paclitaxel for Injection by Company
3.1 Global Paclitaxel for Injection Breakdown Data by Company
3.1.1 Global Paclitaxel for Injection Annual Sales by Company (2020-2022)
3.1.2 Global Paclitaxel for Injection Sales Market Share by Company (2020-2022)
3.2 Global Paclitaxel for Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Paclitaxel for Injection Revenue by Company (2020-2022)
3.2.2 Global Paclitaxel for Injection Revenue Market Share by Company (2020-2022)
3.3 Global Paclitaxel for Injection Sale Price by Company
3.4 Key Manufacturers Paclitaxel for Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel for Injection Product Location Distribution
3.4.2 Players Paclitaxel for Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Paclitaxel for Injection by Geographic Region
4.1 World Historic Paclitaxel for Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Paclitaxel for Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Paclitaxel for Injection Annual Revenue by Geographic Region
4.2 World Historic Paclitaxel for Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Paclitaxel for Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Paclitaxel for Injection Annual Revenue by Country/Region
4.3 Americas Paclitaxel for Injection Sales Growth
4.4 APAC Paclitaxel for Injection Sales Growth
4.5 Europe Paclitaxel for Injection Sales Growth
4.6 Middle East & Africa Paclitaxel for Injection Sales Growth
5 Americas
5.1 Americas Paclitaxel for Injection Sales by Country
5.1.1 Americas Paclitaxel for Injection Sales by Country (2017-2022)
5.1.2 Americas Paclitaxel for Injection Revenue by Country (2017-2022)
5.2 Americas Paclitaxel for Injection Sales by Type
5.3 Americas Paclitaxel for Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel for Injection Sales by Region
6.1.1 APAC Paclitaxel for Injection Sales by Region (2017-2022)
6.1.2 APAC Paclitaxel for Injection Revenue by Region (2017-2022)
6.2 APAC Paclitaxel for Injection Sales by Type
6.3 APAC Paclitaxel for Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Paclitaxel for Injection by Country
7.1.1 Europe Paclitaxel for Injection Sales by Country (2017-2022)
7.1.2 Europe Paclitaxel for Injection Revenue by Country (2017-2022)
7.2 Europe Paclitaxel for Injection Sales by Type
7.3 Europe Paclitaxel for Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Paclitaxel for Injection by Country
8.1.1 Middle East & Africa Paclitaxel for Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Paclitaxel for Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Paclitaxel for Injection Sales by Type
8.3 Middle East & Africa Paclitaxel for Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel for Injection
10.3 Manufacturing Process Analysis of Paclitaxel for Injection
10.4 Industry Chain Structure of Paclitaxel for Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel for Injection Distributors
11.3 Paclitaxel for Injection Customer
12 World Forecast Review for Paclitaxel for Injection by Geographic Region
12.1 Global Paclitaxel for Injection Market Size Forecast by Region
12.1.1 Global Paclitaxel for Injection Forecast by Region (2023-2028)
12.1.2 Global Paclitaxel for Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Paclitaxel for Injection Forecast by Type
12.7 Global Paclitaxel for Injection Forecast by Application
13 Key Players Analysis
13.1 Getwell Pharmaceuticals
13.1.1 Getwell Pharmaceuticals Company Information
13.1.2 Getwell Pharmaceuticals Paclitaxel for Injection Product Offered
13.1.3 Getwell Pharmaceuticals Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Getwell Pharmaceuticals Main Business Overview
13.1.5 Getwell Pharmaceuticals Latest Developments
13.2 CSPC Pharmaceutical Group Limited
13.2.1 CSPC Pharmaceutical Group Limited Company Information
13.2.2 CSPC Pharmaceutical Group Limited Paclitaxel for Injection Product Offered
13.2.3 CSPC Pharmaceutical Group Limited Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSPC Pharmaceutical Group Limited Main Business Overview
13.2.5 CSPC Pharmaceutical Group Limited Latest Developments
13.3 AdvaCare Pharma
13.3.1 AdvaCare Pharma Company Information
13.3.2 AdvaCare Pharma Paclitaxel for Injection Product Offered
13.3.3 AdvaCare Pharma Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AdvaCare Pharma Main Business Overview
13.3.5 AdvaCare Pharma Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Paclitaxel for Injection Product Offered
13.4.3 Pfizer Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Bristol-Myers Squibb
13.5.1 Bristol-Myers Squibb Company Information
13.5.2 Bristol-Myers Squibb Paclitaxel for Injection Product Offered
13.5.3 Bristol-Myers Squibb Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bristol-Myers Squibb Main Business Overview
13.5.5 Bristol-Myers Squibb Latest Developments
13.6 Celgene Corporation
13.6.1 Celgene Corporation Company Information
13.6.2 Celgene Corporation Paclitaxel for Injection Product Offered
13.6.3 Celgene Corporation Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Celgene Corporation Main Business Overview
13.6.5 Celgene Corporation Latest Developments
13.7 Hospira
13.7.1 Hospira Company Information
13.7.2 Hospira Paclitaxel for Injection Product Offered
13.7.3 Hospira Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hospira Main Business Overview
13.7.5 Hospira Latest Developments
13.8 Biological E.
13.8.1 Biological E. Company Information
13.8.2 Biological E. Paclitaxel for Injection Product Offered
13.8.3 Biological E. Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Biological E. Main Business Overview
13.8.5 Biological E. Latest Developments
13.9 Taj Accura
13.9.1 Taj Accura Company Information
13.9.2 Taj Accura Paclitaxel for Injection Product Offered
13.9.3 Taj Accura Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Taj Accura Main Business Overview
13.9.5 Taj Accura Latest Developments
13.10 Luye Pharma
13.10.1 Luye Pharma Company Information
13.10.2 Luye Pharma Paclitaxel for Injection Product Offered
13.10.3 Luye Pharma Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Luye Pharma Main Business Overview
13.10.5 Luye Pharma Latest Developments
13.11 Beijing Youcare
13.11.1 Beijing Youcare Company Information
13.11.2 Beijing Youcare Paclitaxel for Injection Product Offered
13.11.3 Beijing Youcare Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Beijing Youcare Main Business Overview
13.11.5 Beijing Youcare Latest Developments
13.12 Hainan Chuntch Pharmaceutical Co Ltd
13.12.1 Hainan Chuntch Pharmaceutical Co Ltd Company Information
13.12.2 Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Product Offered
13.12.3 Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Hainan Chuntch Pharmaceutical Co Ltd Main Business Overview
13.12.5 Hainan Chuntch Pharmaceutical Co Ltd Latest Developments
13.13 Healthiza Lifescience Private Limited
13.13.1 Healthiza Lifescience Private Limited Company Information
13.13.2 Healthiza Lifescience Private Limited Paclitaxel for Injection Product Offered
13.13.3 Healthiza Lifescience Private Limited Paclitaxel for Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Healthiza Lifescience Private Limited Main Business Overview
13.13.5 Healthiza Lifescience Private Limited Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Paclitaxel for Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Paclitaxel for Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 5ml,30mg
Table 4. Major Players of 10ml,60mg
Table 5. Major Players of Others
Table 6. Global Paclitaxel for Injection Sales by Type (2017-2022) & (K Units)
Table 7. Global Paclitaxel for Injection Sales Market Share by Type (2017-2022)
Table 8. Global Paclitaxel for Injection Revenue by Type (2017-2022) & ($ million)
Table 9. Global Paclitaxel for Injection Revenue Market Share by Type (2017-2022)
Table 10. Global Paclitaxel for Injection Sale Price by Type (2017-2022) & (US$/Unit)
Table 11. Global Paclitaxel for Injection Sales by Application (2017-2022) & (K Units)
Table 12. Global Paclitaxel for Injection Sales Market Share by Application (2017-2022)
Table 13. Global Paclitaxel for Injection Revenue by Application (2017-2022)
Table 14. Global Paclitaxel for Injection Revenue Market Share by Application (2017-2022)
Table 15. Global Paclitaxel for Injection Sale Price by Application (2017-2022) & (US$/Unit)
Table 16. Global Paclitaxel for Injection Sales by Company (2020-2022) & (K Units)
Table 17. Global Paclitaxel for Injection Sales Market Share by Company (2020-2022)
Table 18. Global Paclitaxel for Injection Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Paclitaxel for Injection Revenue Market Share by Company (2020-2022)
Table 20. Global Paclitaxel for Injection Sale Price by Company (2020-2022) & (US$/Unit)
Table 21. Key Manufacturers Paclitaxel for Injection Producing Area Distribution and Sales Area
Table 22. Players Paclitaxel for Injection Products Offered
Table 23. Paclitaxel for Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Paclitaxel for Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Paclitaxel for Injection Sales Market Share Geographic Region (2017-2022)
Table 28. Global Paclitaxel for Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Paclitaxel for Injection Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Paclitaxel for Injection Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Paclitaxel for Injection Sales Market Share by Country/Region (2017-2022)
Table 32. Global Paclitaxel for Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Paclitaxel for Injection Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Paclitaxel for Injection Sales by Country (2017-2022) & (K Units)
Table 35. Americas Paclitaxel for Injection Sales Market Share by Country (2017-2022)
Table 36. Americas Paclitaxel for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Paclitaxel for Injection Revenue Market Share by Country (2017-2022)
Table 38. Americas Paclitaxel for Injection Sales by Type (2017-2022) & (K Units)
Table 39. Americas Paclitaxel for Injection Sales Market Share by Type (2017-2022)
Table 40. Americas Paclitaxel for Injection Sales by Application (2017-2022) & (K Units)
Table 41. Americas Paclitaxel for Injection Sales Market Share by Application (2017-2022)
Table 42. APAC Paclitaxel for Injection Sales by Region (2017-2022) & (K Units)
Table 43. APAC Paclitaxel for Injection Sales Market Share by Region (2017-2022)
Table 44. APAC Paclitaxel for Injection Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Paclitaxel for Injection Revenue Market Share by Region (2017-2022)
Table 46. APAC Paclitaxel for Injection Sales by Type (2017-2022) & (K Units)
Table 47. APAC Paclitaxel for Injection Sales Market Share by Type (2017-2022)
Table 48. APAC Paclitaxel for Injection Sales by Application (2017-2022) & (K Units)
Table 49. APAC Paclitaxel for Injection Sales Market Share by Application (2017-2022)
Table 50. Europe Paclitaxel for Injection Sales by Country (2017-2022) & (K Units)
Table 51. Europe Paclitaxel for Injection Sales Market Share by Country (2017-2022)
Table 52. Europe Paclitaxel for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Paclitaxel for Injection Revenue Market Share by Country (2017-2022)
Table 54. Europe Paclitaxel for Injection Sales by Type (2017-2022) & (K Units)
Table 55. Europe Paclitaxel for Injection Sales Market Share by Type (2017-2022)
Table 56. Europe Paclitaxel for Injection Sales by Application (2017-2022) & (K Units)
Table 57. Europe Paclitaxel for Injection Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Paclitaxel for Injection Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Paclitaxel for Injection Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Paclitaxel for Injection Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Paclitaxel for Injection Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Paclitaxel for Injection Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Paclitaxel for Injection Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Paclitaxel for Injection Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Paclitaxel for Injection Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Paclitaxel for Injection
Table 67. Key Market Challenges & Risks of Paclitaxel for Injection
Table 68. Key Industry Trends of Paclitaxel for Injection
Table 69. Paclitaxel for Injection Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Paclitaxel for Injection Distributors List
Table 72. Paclitaxel for Injection Customer List
Table 73. Global Paclitaxel for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Paclitaxel for Injection Sales Market Forecast by Region
Table 75. Global Paclitaxel for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Paclitaxel for Injection Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Paclitaxel for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Paclitaxel for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Paclitaxel for Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Paclitaxel for Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Paclitaxel for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Paclitaxel for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Paclitaxel for Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Paclitaxel for Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Paclitaxel for Injection Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Paclitaxel for Injection Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Paclitaxel for Injection Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Paclitaxel for Injection Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Paclitaxel for Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Paclitaxel for Injection Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Paclitaxel for Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Paclitaxel for Injection Revenue Market Share Forecast by Application (2023-2028)
Table 93. Getwell Pharmaceuticals Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 94. Getwell Pharmaceuticals Paclitaxel for Injection Product Offered
Table 95. Getwell Pharmaceuticals Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 96. Getwell Pharmaceuticals Main Business
Table 97. Getwell Pharmaceuticals Latest Developments
Table 98. CSPC Pharmaceutical Group Limited Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 99. CSPC Pharmaceutical Group Limited Paclitaxel for Injection Product Offered
Table 100. CSPC Pharmaceutical Group Limited Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 101. CSPC Pharmaceutical Group Limited Main Business
Table 102. CSPC Pharmaceutical Group Limited Latest Developments
Table 103. AdvaCare Pharma Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 104. AdvaCare Pharma Paclitaxel for Injection Product Offered
Table 105. AdvaCare Pharma Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 106. AdvaCare Pharma Main Business
Table 107. AdvaCare Pharma Latest Developments
Table 108. Pfizer Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Paclitaxel for Injection Product Offered
Table 110. Pfizer Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 111. Pfizer Main Business
Table 112. Pfizer Latest Developments
Table 113. Bristol-Myers Squibb Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 114. Bristol-Myers Squibb Paclitaxel for Injection Product Offered
Table 115. Bristol-Myers Squibb Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 116. Bristol-Myers Squibb Main Business
Table 117. Bristol-Myers Squibb Latest Developments
Table 118. Celgene Corporation Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 119. Celgene Corporation Paclitaxel for Injection Product Offered
Table 120. Celgene Corporation Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 121. Celgene Corporation Main Business
Table 122. Celgene Corporation Latest Developments
Table 123. Hospira Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 124. Hospira Paclitaxel for Injection Product Offered
Table 125. Hospira Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 126. Hospira Main Business
Table 127. Hospira Latest Developments
Table 128. Biological E. Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 129. Biological E. Paclitaxel for Injection Product Offered
Table 130. Biological E. Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 131. Biological E. Main Business
Table 132. Biological E. Latest Developments
Table 133. Taj Accura Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 134. Taj Accura Paclitaxel for Injection Product Offered
Table 135. Taj Accura Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 136. Taj Accura Main Business
Table 137. Taj Accura Latest Developments
Table 138. Luye Pharma Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 139. Luye Pharma Paclitaxel for Injection Product Offered
Table 140. Luye Pharma Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 141. Luye Pharma Main Business
Table 142. Luye Pharma Latest Developments
Table 143. Beijing Youcare Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 144. Beijing Youcare Paclitaxel for Injection Product Offered
Table 145. Beijing Youcare Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 146. Beijing Youcare Main Business
Table 147. Beijing Youcare Latest Developments
Table 148. Hainan Chuntch Pharmaceutical Co Ltd Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 149. Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Product Offered
Table 150. Hainan Chuntch Pharmaceutical Co Ltd Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 151. Hainan Chuntch Pharmaceutical Co Ltd Main Business
Table 152. Hainan Chuntch Pharmaceutical Co Ltd Latest Developments
Table 153. Healthiza Lifescience Private Limited Basic Information, Paclitaxel for Injection Manufacturing Base, Sales Area and Its Competitors
Table 154. Healthiza Lifescience Private Limited Paclitaxel for Injection Product Offered
Table 155. Healthiza Lifescience Private Limited Paclitaxel for Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 156. Healthiza Lifescience Private Limited Main Business
Table 157. Healthiza Lifescience Private Limited Latest Developments
List of Figures
Figure 1. Picture of Paclitaxel for Injection
Figure 2. Paclitaxel for Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel for Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Paclitaxel for Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Paclitaxel for Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 5ml,30mg
Figure 10. Product Picture of 10ml,60mg
Figure 11. Product Picture of Others
Figure 12. Global Paclitaxel for Injection Sales Market Share by Type in 2021
Figure 13. Global Paclitaxel for Injection Revenue Market Share by Type (2017-2022)
Figure 14. Paclitaxel for Injection Consumed in Ovarian Cancer
Figure 15. Global Paclitaxel for Injection Market: Ovarian Cancer (2017-2022) & (K Units)
Figure 16. Paclitaxel for Injection Consumed in Breast Cancer
Figure 17. Global Paclitaxel for Injection Market: Breast Cancer (2017-2022) & (K Units)
Figure 18. Paclitaxel for Injection Consumed in Cervical Cancer
Figure 19. Global Paclitaxel for Injection Market: Cervical Cancer (2017-2022) & (K Units)
Figure 20. Paclitaxel for Injection Consumed in Pancreatic Cancer
Figure 21. Global Paclitaxel for Injection Market: Pancreatic Cancer (2017-2022) & (K Units)
Figure 22. Paclitaxel for Injection Consumed in Others
Figure 23. Global Paclitaxel for Injection Market: Others (2017-2022) & (K Units)
Figure 24. Global Paclitaxel for Injection Sales Market Share by Application (2017-2022)
Figure 25. Global Paclitaxel for Injection Revenue Market Share by Application in 2021
Figure 26. Paclitaxel for Injection Revenue Market by Company in 2021 ($ Million)
Figure 27. Global Paclitaxel for Injection Revenue Market Share by Company in 2021
Figure 28. Global Paclitaxel for Injection Sales Market Share by Geographic Region (2017-2022)
Figure 29. Global Paclitaxel for Injection Revenue Market Share by Geographic Region in 2021
Figure 30. Global Paclitaxel for Injection Sales Market Share by Region (2017-2022)
Figure 31. Global Paclitaxel for Injection Revenue Market Share by Country/Region in 2021
Figure 32. Americas Paclitaxel for Injection Sales 2017-2022 (K Units)
Figure 33. Americas Paclitaxel for Injection Revenue 2017-2022 ($ Millions)
Figure 34. APAC Paclitaxel for Injection Sales 2017-2022 (K Units)
Figure 35. APAC Paclitaxel for Injection Revenue 2017-2022 ($ Millions)
Figure 36. Europe Paclitaxel for Injection Sales 2017-2022 (K Units)
Figure 37. Europe Paclitaxel for Injection Revenue 2017-2022 ($ Millions)
Figure 38. Middle East & Africa Paclitaxel for Injection Sales 2017-2022 (K Units)
Figure 39. Middle East & Africa Paclitaxel for Injection Revenue 2017-2022 ($ Millions)
Figure 40. Americas Paclitaxel for Injection Sales Market Share by Country in 2021
Figure 41. Americas Paclitaxel for Injection Revenue Market Share by Country in 2021
Figure 42. United States Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 43. Canada Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Mexico Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. Brazil Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. APAC Paclitaxel for Injection Sales Market Share by Region in 2021
Figure 47. APAC Paclitaxel for Injection Revenue Market Share by Regions in 2021
Figure 48. China Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Japan Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 50. South Korea Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 51. Southeast Asia Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. India Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. Australia Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Europe Paclitaxel for Injection Sales Market Share by Country in 2021
Figure 55. Europe Paclitaxel for Injection Revenue Market Share by Country in 2021
Figure 56. Germany Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 57. France Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 58. UK Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. Italy Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Russia Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Middle East & Africa Paclitaxel for Injection Sales Market Share by Country in 2021
Figure 62. Middle East & Africa Paclitaxel for Injection Revenue Market Share by Country in 2021
Figure 63. Egypt Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 64. South Africa Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 65. Israel Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 66. Turkey Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 67. GCC Country Paclitaxel for Injection Revenue Growth 2017-2022 ($ Millions)
Figure 68. Manufacturing Cost Structure Analysis of Paclitaxel for Injection in 2021
Figure 69. Manufacturing Process Analysis of Paclitaxel for Injection
Figure 70. Industry Chain Structure of Paclitaxel for Injection
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets